Official Louisiana State Websites use .la.gov 
Secure .gov websites use HTTPS 
Results for provider policy
-
Info
WIC Complaint and Fraud Procedure
A WIC Civil Rights Complaint results when an individual believes and indicates they were treated differently because of their race, color, national origin, sex, disability, age, or reprisal or retaliation for prior civil rights activity in any program or activity conducted or funded by USDA.
-
Info
What healthcare professionals need to know about lead
Here you'll find information on care coordination, case management, clinical guidelines for testing, and further help in regard to the complex resource system for patient support and services following a positive lead test.
-
Info
Louisiana Operator Certification Program
Welcome to the Operator Certification website. Here you will find current information related to this program.
-
Info
Medicaid Managed Care Policies & Procedures Archive (2019)
-
Info
Medicaid Advisory Committee
-
Info
Frequently Asked Questions
Frequently asked questions about lead poisoning.
-
Info
Louisiana Environmental Public Health Tracking
Environmental Public Health Tracking provides data and information on health outcomes, the environment, population, and exposures.
-
Info
What parents and caregivers need to know about lead
Partnerships make us stronger and we want to partner with the families we serve! Here you'll find information about lead poisoning prevention, supportive services and how to make your home lead-safe.
-
Info
Medicaid State Plan CHIP
-
Info
Medicaid State Plan Amendments 2013
-
Info
Medicaid State Plan Amendments 2014
-
Info
Governance Board Document Archives
Governance Board Document Archives
-
Info
Managed Care Pharmacy and Medical Drug Policies Archive (2024)
-
Info
Lead Service Line Inventory (LSLI)
-
Resource
Legislative Report on the Louisiana Rare Disease Advisory Council, SFY2023
The Louisiana Rare Disease Advisory Council (LA RDAC) is a statutorily mandated advisory group that is charged with serving in a resource capacity to any public and private agency located in this state that provides services for a person who has been diagnosed with a rare disease. The LA RDAC is administered through the Louisiana Department of Health (LDH or the Department) Office of Public Health (OPH) Bureau of Family Health (BFH), which provides staff support and policy expertise to assist the group with carrying out its charge.
-
Info
Onboarding & Other Resources
LDH Employee Orientation Information
-
Info
Act. 367 ( House Bill 291)
Act 367 enacts reform that Provides for visitation policies at certain healthcare facilities and requires that such policies allow for in-person visitation, relative to minimum standards for visitation policies at certain healthcare facilities; to require in-person visitation under certain circumstances; to provide minimum requirements for in-person visits; to provide for certain physical contact; to require the provision of visitation policy information with applications for licensure, renewal of licensure, or change of ownership; to require publication of visitation policies; and to provide for related matters.
-
Info
OAAS Quarterly Provider Meetings
This page contains copies of the presentations delivered at OAAS Quarterly Provider meetings across the state.
-
Info
Medicaid Managed Care Policies & Procedures Archive (2022)
-
Resource
2024 Louisiana Rare Disease Advisory Council Report
The Louisiana Rare Disease Advisory Council provides resources to public and private agencies in the state that serve individuals diagnosed with rare diseases. The Council is tasked with compiling an annual report that summarizes the findings, activities, and progress for State Fiscal Year 2024 (SFY 2024) of the Council and recommendations for addressing the needs of Louisianans living with a rare disease. The Council operates under the Bureau of Family Health, which provides staff support and policy expertise to assist the Council in fulfilling its mission to provide advice on research, diagnosis, treatment, and education related to rare diseases. The Council's additional duties, outlined in R.S. 40:1122.1 (see Appendix D), include providing expert and clinical advice to the Drug Utilization Review Board in its review of treatments for rare diseases and providing input and feedback to the Louisiana Department of Health and other agencies on matters affecting people with rare diseases.